美股市場個股詳情
CPRX Catalyst Pharmaceuticals
- 21.480
- +0.360+1.70%
收盤價 11/22 16:00 (美東)
- 21.100
- -0.380-1.77%
盤後 19:54 (美東)
25.62億總市值18.20市盈率TTM
21.550最高價21.050最低價86.39萬股成交量21.180今開21.120昨收1851.32萬成交額0.82%換手率34.10市盈率(靜)1.19億總股本24.27052周最高3.88市淨率22.75億流通值13.00052周最低--股息TTM1.06億流通股24.270歷史最高--股息率TTM2.37%振幅0.370歷史最低21.430平均價1股每手
關於Catalyst Pharmaceuticals公司
Catalyst Pharmaceuticals Inc是一家生物製藥公司。該公司專注於爲患有罕見、衰弱、慢性神經肌肉疾病和神經系統疾病的人開發創新療法並將其商業化。該公司供應Firdapse，一種專利形式的磷酸阿米吡啶片，用於治療Lambbert-eaton肌無力綜合症患者。
公司介紹
公司代碼CPRX
公司名稱Catalyst Pharmaceuticals
上市日期2006/11/08
發行價格6.00
成立日期2002
CEOMr. Richard J. Daly
所屬市場納斯達克
員工數量167
年結日12-31
公司地址355 Alhambra Circle,Suite 801
城市Coral Gables
省份佛羅里達州
國家美國
郵編33134
電話1-305-420-3200
董事高管
- 姓名
- 職務
- 年薪
- Richard J. Daly
- Director, President and Chief Executive Officer
- 1407.69萬
- Dr. Steven R. Miller,PhD
- Executive Vice President, Chief Operating Officer and Chief Scientific Officer
- 340.47萬
- Dr. Preethi Sundaram, PhD
- Chief Strategy Officer
- --
- Michael W. Kalb
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- --
- Jeffrey Del Carmen
- Executive Vice President and Chief Commercial Officer
- 250.61萬
- Dr. Gary Ingenito,M.D.,PhD
- Chief Medical and Regulatory Officer
- 237.14萬
- Brian Elsbernd, J.D.
- Chief Compliance Officer and Chief Legal Officer
- --
- Patrick J. McEnany
- Non-Executive Chairman of the Board
- 214.65萬
- Dr. David S. Tierney,M.D.
- Independent Director
- 37.10萬
- Molly Harper
- Independent Director
- 36.31萬
- Charles B. O'Keeffe
- Lead Independent Director
- 39.72萬
- Tamar Thompson
- Independent Director
- 61.04萬
- Donald A. Denkhaus
- Independent Director
- 37.62萬
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據